Stifel on Oruka Therapeutics (ORKA): 'We expect shares to trade meaningfully-higher'
Stifel analyst Alex Thompson reiterated a Buy rating and $72.00 price target on Oruka Therapeutics (NASDAQ: ORKA).The analyst comments "16wk ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)